Background
==========

Sepsis is characterized by systemic inflammation (systemic inflammatory response syndrome (SIRS)), leading to multiple organ failure and death. The lung and liver are both prone to septic-induced damage resulting from leukocyte infiltration, cellular apoptosis, and epithelial/endothelial breakdown. Furthermore, coagulation can potentiate the inflammatory response and contribute to septic mortality. Phosphoinositide-3 kinase gamma (PI3Kγ) plays a dominant role in the inflammatory response; however, its role in the pathogenesis of sepsis, specifically SIRS, lung/liver inflammation and damage, apoptosis, coagulation and mortality remains unknown. We hypothesized that mice lacking PI3Kγ or possessing a kinase-dead enzyme will be protected against septic-induced injury.

Methods
=======

PI3Kγ wild-type (WT), knockout (KO) and kinase dead (KD) mice were randomized to cecal ligation and perforation (CLP)-induced sepsis or a sham laporatomy. After 18 hours, plasma and bronchoalveolar lavage and/or lung and liver tissue were collected. Plasma was assessed for inflammatory mediators and the lung/liver was analysed for pathology score, leukocyte infiltration, inflammatory mediators, edema, apoptosis, coagulation and downstream intracellular signalling of PI3Kγ. A separate cohort of WT and KO mice were used for evaluation of 7-day survival following CLP.

Results
=======

Systemically, KO and KD mice showed a reduction in five of 22 measured cytokines/chemokines (MIP1a, MIP2, RANTES, MCP1 and IL-10) compared with WT controls. In the lungs, KO and KD mice were significantly protected against septic damage, as observed by decreased pathology scores, edema/permeability, leukocyte infiltration, inflammation (all 22 measured mediators), apoptosis and Akt/mitogen-activated protein kinase activation, compared with WT lungs. Similarly, livers of CLP-exposed KO and KD mice had decreased pathology scores, leukocyte infiltration, apoptosis and coagulation derangements compared with WT controls. Furthermore, Kaplan--Meier analysis of 7-day survival following CLP showed KO mice had significantly reduced mortality compared with WT mice. See Table [1](#T1){ref-type="table"}.

###### 

Portion of results displaying the systemic, lung, liver and coagulation responses of PI3KγWT, KO and KD mice to CLP-induced sepsis

                                                      WT sham       KO sham       KD sham       WT CLP            KO CLP          KD CLP
  --------------------------------------------------- ------------- ------------- ------------- ----------------- --------------- ---------------
  Systemic response                                                                                                               
   MIP-2 concentration (pg/ml in plasma × 10^4^)      0 ± 0         0 ± 0         0 ± 0         13 ± 5\*\*        2 ± 1\*         2 ± 1\*
   IL-6 concentration (pg/ml in plasma × 10^3^)       0 ± 0         0 ± 0         0 ± 0         18 ± 5\*          19 ± 10\*       22 ± 8\*
  Lung injury                                                                                                                     
   Pathology score                                    1.67 ± 0.42   1.8 ± 0.49    1.71 ± 0.42   4.17 ± 0.31\*     2.00 ± 0.63     2.00 ± 0.45
   Permeability (protein in BAL (μg/ml))              194 ± 7       199 ± 3       195 ± 8       234 ± 13\*        191 ± 13        192 ± 10
   Neutrophil infiltration (cell × 10^3^/ml BAL)      0.3 ± 0.2     0.8 ± 0.4     0.2 ± 0.2     11.7 ± 5.9\*      0.2 ± 0.1       0.8 ± 0.3
   MIP-2 concentration (pg/ml in BAL × 10^2^)         0 ± 0         0 ± 0         0 ± 0         21.6 ± 1.0\*      1.1 ± 0.4       1.2 ± 0.5
   IL-6 concentration (pg/ml in BAL × 10^2^)          0 ± 0         0 ± 0         0 ± 0         14 ± 5\*          1 ± 0           2 ± 0
   Apoptosis (% apoptotic cells)                      0.3 ± 0.1     1.2 ± 0.2\*   1.0 ± 0.2\*   7.7 ± 0.8\*\*     1.3 ± 0.3\*     1.2 ± 0.3\*
   Akt phosphorylation (fold increase over WT sham)   1.0 ± 0.1     0.7 ± 0.0\*   0.7 ± 0.1\*   1.4 ± 0.1\*\*     0.8 ± 0.1\*     0.8 ± 0.1\*
  Liver injury                                                                                                                    
   Pathology score                                    0.33 ± 0.21   0.20 ± 0.20   0.20 ± 0.20   2.83 ± 0.17\*\*   1.20 ± 0.37\*   1.83 ± 0.17\*
   Apoptosis (% apoptotic cells)                      1.0 ± 0.2     4.6 ± 1.2\*   4.3 ± 1.0\*   23.9 ± 2.7\*\*    5.6 ± 0.7\*     4.9 ± 1.0\*
  Coagulation                                                                                                                     
   tPA (pg/ng protein)                                404 ± 17      369 ± 53      423 ± 23      1 ± 1\*\*         104 ± 36\*      61 ± 31\*
   PAI-1 (pg/μg protein)                              2.9 ± 0.2     2.7 ± 0.2     3.1 ± 0.4     84.8 ± 13.4\*\*   50.5 ± 9.2\*    52.0 ± 9.0\*
   Fibrinogen (ng/mg protein)                         805 ± 35      807 ± 40      779 ± 33      1424 ± 89\*\*     1043 ± 57\*     1079 ± 58\*

BAL, bronchoalveolar lavage; tPA, tissue plasminogen activator; PAI-1, plasminogen activator inhibitor 1.

Conclusion
==========

The present study demonstrates that while PI3Kγ has a modest effect on SIRS during sepsis, its kinase activity is pivotal to the successive development of coagulation derangement and lung/liver inflammation and damage, probably through the modification of leukocyte recruitment and apoptosis. Furthermore, PI3Kγ is shown to effect CLP-septic-induced mortality, implying that it may be a possible therapeutic target in sepsis and multiple organ failure.
